U.S. Protein Chip Market was valued at USD 0.96 billion in 2025 and is expected to reach USD 1.87 billion by 2035 due to world-class academic and research infrastructureAustin, April 01, 2026 (GLOBE ...

Autoimmune diseases that stem from an autoaggression of the immune system toward a subject's own tissues and organs still represent a field of intense research in the hope to identify why this occurs ...

The "Protein Microarrays - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Protein Microarrays was estimated at US$4.6 Billion in ...

Planar waveguide (PWG) technology (right) has the advantage over conventional epifluorescence excitation (left) for surface-confined assays in that only surface-bound fluorphores respond to the ...

Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas ABSTRACT: ...

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.

Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental ...

A tutorial session held by Dr. Robinson and Dr. Haab [17] provided more details on the technical aspects of the protein microarrays they are developing. In principle, chips can be considered "capture ...